Gelesis Holdings Inc at UBS Global Healthcare Conference Transcript
Okay. Good morning, everyone. Thank you for joining us for day 3 of the UBS Global Healthcare Conference in person. I'm Ellie Merle. I'm one of the biotech analysts here at UBS. Very happy to have Gelesis presenting with us today. Joining us from Gelesis is Yishai Zohar, Founder and CEO; Elliot Maltz, Chief Financial Officer; and David Pass, Chief Operating and Commercial Officer.
And with that, I will turn it to you guys.
Thank you, Ellie, and the UBS team for inviting us presenting the conference. Of course, also, thank you all joining us in person and on the webcast. I'm happy to be here with my colleagues to tell you about our company and its positioning as a potential leader in the exciting and growing category of obesity therapeutics. We are going to make forward-looking statements. And I ask you refer to our SEC filings to review potential risks and uncertainties. All the information is current as
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
